TONAR Posted July 16, 2016 Share Posted July 16, 2016 I am on Xtandi and my Oncologist wants to monitor liver function every fortnight. However, I notice in the Public Summary Document for Xtandi (dated July, 2014) that: 1.1 On the basis of indirect evidence presented by the submission, enzalutamide is well tolerated and appears to have a similar safety profile to abiraterone, but does not require monitoring of liver function and blood pressure, which is required with abiraterone. Does anyone have any Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.